Year: 2017
Type: article
Abstract: For decades, intravenous immunoglobulin (IVIg) has provided safe and effective therapy for immunodeficient patients. This proof-of-principle study describes a novel approach to generate personalized IVIg for chronic, antibiotic-resistant infection in real time.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/cix977
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Brigham and Women's Hospital
OpenAlex ID: W2778322495
